Reporting guidelines for human microbiome research: the STORMS checklist.

Computational Biology / methods Dysbiosis / microbiology Humans Microbiota / physiology Observational Studies as Topic / methods Research Design Translational Science, Biomedical

Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
11 2021
Historique:
received: 01 12 2020
accepted: 23 09 2021
pubmed: 19 11 2021
medline: 30 12 2021
entrez: 18 11 2021
Statut: ppublish

Résumé

The particularly interdisciplinary nature of human microbiome research makes the organization and reporting of results spanning epidemiology, biology, bioinformatics, translational medicine and statistics a challenge. Commonly used reporting guidelines for observational or genetic epidemiology studies lack key features specific to microbiome studies. Therefore, a multidisciplinary group of microbiome epidemiology researchers adapted guidelines for observational and genetic studies to culture-independent human microbiome studies, and also developed new reporting elements for laboratory, bioinformatics and statistical analyses tailored to microbiome studies. The resulting tool, called 'Strengthening The Organization and Reporting of Microbiome Studies' (STORMS), is composed of a 17-item checklist organized into six sections that correspond to the typical sections of a scientific publication, presented as an editable table for inclusion in supplementary materials. The STORMS checklist provides guidance for concise and complete reporting of microbiome studies that will facilitate manuscript preparation, peer review, and reader comprehension of publications and comparative analysis of published results.

Identifiants

DOI: 10.1038/s41591-021-01552-x PMID: 34789871 PMC: PMC9105086
pubmed: 34789871
doi: 10.1038/s41591-021-01552-x
pii: 10.1038/s41591-021-01552-x
pmc: PMC9105086
mid: NIHMS1801461
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1885-1892

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM135218
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/E025080/1
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK098722
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA230551
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA230551
Pays : United States

Investigateurs

Cesare Furlanello (C)
Susanna-Assunta Sansone (SA)

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679–689 (2019).
pubmed: 30936547 pmcid: 7984229 doi: 10.1038/s41591-019-0406-6
Simoneau, J., Dumontier, S., Gosselin, R. & Scott, M. S. Current RNA-seq methodology reporting limits reproducibility. Brief. Bioinform. 22, 140–145 (2021).
pubmed: 31813948 doi: 10.1093/bib/bbz124
Ten Hoopen, P. et al. The metagenomic data life-cycle: standards and best practices. Gigascience 6, 1–11 (2017).
pubmed: 28637310 pmcid: 5737865
Yilmaz, P. et al. Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications. Nat. Biotechnol. 29, 415–420 (2011).
pubmed: 21552244 pmcid: 3367316 doi: 10.1038/nbt.1823
Moher, D., Jones, A. & Lepage, L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. J. Am. Med. Assoc. 285, 1992–1995 (2001).
doi: 10.1001/jama.285.15.1992
Plint, A. C. et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? Syst. Rev. 185, 5 (2006).
Vandenbroucke, J. P. et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 4, e297 (2007).
pubmed: 17941715 pmcid: 2020496 doi: 10.1371/journal.pmed.0040297
Little, J. et al. STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement. Genet. Epidemiol. 33, 581–598 (2009).
pubmed: 19278015 doi: 10.1002/gepi.20410
Bharucha, T. et al. STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies. Lancet Infect. Dis. 20, e251–e260 (2020).
pubmed: 32768390 pmcid: 7406238 doi: 10.1016/S1473-3099(20)30199-7
Sinha, R. et al. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat. Biotechnol. 35, 1077–1086 (2017).
pubmed: 28967885 pmcid: 5839636 doi: 10.1038/nbt.3981
Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
pubmed: 28967887 doi: 10.1038/nbt.3960
Santiago, A. et al. Processing faecal samples: a step forward for standards in microbial community analysis. BMC Microbiol. 14, 112 (2014).
pubmed: 24884524 pmcid: 4021188 doi: 10.1186/1471-2180-14-112
Turner, P. et al. Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data. BMC Med. 17, 70 (2019).
pubmed: 30922309 pmcid: 6440102 doi: 10.1186/s12916-019-1301-1
Kerns, S. L. et al. STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics - ScienceDirect. Radiother. Oncol. 110, 182–188 (2014).
pubmed: 23993398 doi: 10.1016/j.radonc.2013.07.011
Sinha, R., Abnet, C. C., White, O., Knight, R. & Huttenhower, C. The microbiome quality control project: baseline study design and future directions. Genome Biol. 16, 276 (2015).
pubmed: 26653756 pmcid: 4674991 doi: 10.1186/s13059-015-0841-8
Badal, V. D. et al. Challenges in the construction of knowledge bases for human microbiome-disease associations. Microbiome 7, 129 (2019).
pubmed: 31488215 pmcid: 6728997 doi: 10.1186/s40168-019-0742-2
von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344–349 (2008).
doi: 10.1016/j.jclinepi.2007.11.008
Gallo, V. et al. STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur. J. Clin. Invest. 42, 1–16 (2012).
Kerns, S. L. et al. STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother. Oncol. 110, 182–188 (2014).
pubmed: 23993398 doi: 10.1016/j.radonc.2013.07.011
Sinha, R. et al. Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16–17, 2017. Microbiome 6, 210 (2018).
pubmed: 30477563 pmcid: 6257978 doi: 10.1186/s40168-018-0596-z
Hornung, B. V. H., Zwittink, R. D. & Kuijper, E. J. Issues and current standards of controls in microbiome research. FEMS Microbiol. Ecol. 95, fiz045 (2019).
pubmed: 30997495 pmcid: 6469980 doi: 10.1093/femsec/fiz045
Min, Y. et al. Sex-specific association between gut microbiome and fat distribution. Nat. Commun. 10, 2408 (2019).
pubmed: 31160598 pmcid: 6546740 doi: 10.1038/s41467-019-10440-5
Pearce, N. Classification of epidemiological study designs. Int. J. Epidemiol. 41, 393–397 (2012).
pubmed: 22493323 doi: 10.1093/ije/dys049
Jin, Y., Wu, S., Zeng, Z. & Fu, Z. Effects of environmental pollutants on gut microbiota. Environ. Pollut. 222, 1–9 (2017).
pubmed: 28086130 doi: 10.1016/j.envpol.2016.11.045
Chen, L., Zhang, Y.-H., Huang, T. & Cai, Y.-D. Gene expression profiling gut microbiota in different races of humans. Sci. Rep. 6, 23075 (2016).
pubmed: 26975620 pmcid: 4791684 doi: 10.1038/srep23075
Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).
pubmed: 22699611 pmcid: 3376388 doi: 10.1038/nature11053
Patino, C. M., Ferreira, J. C., Patino, C. M. & Ferreira, J. C. Inclusion and exclusion criteria in research studies: definitions and why they matter. J. Bras. Pneumol. 44, 84–84 (2018).
pubmed: 29791550 pmcid: 6044655 doi: 10.1590/s1806-37562018000000088
Yan, L. et al. OSAT: a tool for sample-to-batch allocations in genomics experiments. BMC Genomics 13, 689 (2012).
pubmed: 23228338 pmcid: 3548766 doi: 10.1186/1471-2164-13-689
VanderWeele, T. J. Principles of confounder selection. Eur. J. Epidemiol. 34, 211–219 (2019).
pubmed: 30840181 pmcid: 6447501 doi: 10.1007/s10654-019-00494-6
Hernán, M. A., Hernández-Díaz, S., Werler, M. M. & Mitchell, A. A. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am. J. Epidemiol. 155, 176–184 (2002).
pubmed: 11790682 doi: 10.1093/aje/155.2.176
Lv, B.-M., Quan, Y. & Zhang, H.-Y. Causal inference in microbiome medicine: principles and applications. Trends Microbiol. 29, 736–746 (2021).
pubmed: 33895062 doi: 10.1016/j.tim.2021.03.015
Ghosh, T. S., Das, M., Jeffery, I. B. & O’Toole, P. W. Adjusting for age improves identification of gut microbiome alterations in multiple diseases. eLife 9, e50240 (2020).
pubmed: 32159510 pmcid: 7065848 doi: 10.7554/eLife.50240
Soneson, C., Gerster, S. & Delorenzi, M. Batch effect confounding leads to strong bias in performance estimates obtained by cross-validation. PLoS One 9, e100335 (2014).
pubmed: 24967636 pmcid: 4072626 doi: 10.1371/journal.pone.0100335
Cole, S. R. et al. Illustrating bias due to conditioning on a collider. Int. J. Epidemiol. 39, 417–420 (2010).
pubmed: 19926667 doi: 10.1093/ije/dyp334
Textor, J., van der Zander, B., Gilthorpe, M. S., Liśkiewicz, M. & Ellison, G. T. H. Robust causal inference using directed acyclic graphs: the R package ‘dagitty’. Int. J. Epidemiol. 45, 1887–1894 (2016).
pubmed: 28089956
Loughman, A. et al. Gut microbiota composition during infancy and subsequent behavioural outcomes. EBioMedicine 52, 102640 (2020).
pubmed: 32062351 pmcid: 7016366 doi: 10.1016/j.ebiom.2020.102640
Schooling, C. M. Selection bias in population-representative studies? A commentary on Deaton and Cartwright. Soc. Sci. Med. 210, 70 (2018).
pubmed: 29754782 doi: 10.1016/j.socscimed.2018.04.047
Schloss, P. D. Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research. mBio 9, e00525-18 (2018).
pubmed: 29871915 pmcid: 5989067 doi: 10.1128/mBio.00525-18
Rosenthal, R. The file drawer problem and tolerance for null results. Psychol. Bull. 86, 638–641 (1979).
doi: 10.1037/0033-2909.86.3.638
Munafò, M. & Neill, J. Null is beautiful: On the importance of publishing null results. J. Psychopharmacol. 30, 585–585 (2016).
pubmed: 27313237 doi: 10.1177/0269881116638813
Rich, B. Tables of Descriptive Statistics in HTML [R package table1 version 1.4.2] (2021).
McLaren, M. R., Willis, A. D. & Callahan, B. J. Consistent and correctable bias in metagenomic sequencing experiments. eLife 8, e46923 (2019).
pubmed: 31502536 pmcid: 6739870 doi: 10.7554/eLife.46923
Hernán, M. & Robins, J.M. Causal Inference: What If (Chapman & Hall/CRC, 2020).
Höfler, M. et al. Writing a discussion section: how to integrate substantive and statistical expertise. BMC Med. Res. Methodol. 18, 34 (2018).
pubmed: 29665780 pmcid: 5905138 doi: 10.1186/s12874-018-0490-1
Nakai, M. et al. Essential hypertension is associated with changes in gut microbial metabolic pathways: a multisite analysis of ambulatory blood pressure. Hypertension 78, 804–815 (2021).
pubmed: 34333988 doi: 10.1161/HYPERTENSIONAHA.121.17288
Thingholm, L. B. et al. Ecology impacts the decrease of Spirochaetes and Prevotella in the fecal gut microbiota of urban humans. BMC Microbiol 21, 276 (2021).
pubmed: 34635060 pmcid: 8504008 doi: 10.1186/s12866-021-02337-5
Wang, Q. et al. Linking gut microbiome to bone mineral density: a shotgun metagenomic dataset from 361 elderly women. Gigabyte 2021, 1–7 (2021).
doi: 10.46471/gigabyte.12
Chen, C. et al. The female urinary microbiota in relation to the reproductive tract microbiota. Gigabyte 2020, 1–9 (2020).
doi: 10.46471/gigabyte.9
Raes, J., Foerstner, K. U. & Bork, P. Get the most out of your metagenome: computational analysis of environmental sequence data. Curr. Opin. Microbiol. 10, 490–498 (2007).
pubmed: 17936679 doi: 10.1016/j.mib.2007.09.001
Szucs, D. & Ioannidis, J. P. A. When null hypothesis significance testing is unsuitable for research: a reassessment. Front. Hum. Neurosci. 11, 390 (2017).
pubmed: 28824397 pmcid: 5540883 doi: 10.3389/fnhum.2017.00390
Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V. & Egozcue, J. J. Microbiome datasets are compositional: and this is not optional. Front. Microbiol. 8, 2224 (2017).
pubmed: 29187837 pmcid: 5695134 doi: 10.3389/fmicb.2017.02224

Auteurs

Chloe Mirzayi (C)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Audrey Renson (A)

University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Fatima Zohra (F)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Shaimaa Elsafoury (S)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Ludwig Geistlinger (L)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Lora J Kasselman (LJ)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Kelly Eckenrode (K)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Janneke van de Wijgert (J)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Amy Loughman (A)

Food & Mood Centre, The Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, Victoria, Australia.

Francine Z Marques (FZ)

Hypertension Research Laboratory, School of Biological Sciences, Faculty of Science, Monash University, Melbourne, Victoria, Australia.
ORCID: 0000-0003-4920-9991

David A MacIntyre (DA)

Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.

Manimozhiyan Arumugam (M)

Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Rimsha Azhar (R)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.

Francesco Beghini (F)

Department CIBIO, University of Trento, Trento, Italy.

Kirk Bergstrom (K)

Department of Biology, University of British Columbia-Okanagan Campus, Kelowna, British Columbia, Canada.

Ami Bhatt (A)

Division of Hematology and Division of Bone Marrow Transplantation, Department of Medicine, and Department of Genetics, Stanford University, Stanford, CA, USA.

Jordan E Bisanz (JE)

Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.

Jonathan Braun (J)

Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Hector Corrada Bravo (HC)

Genentech, South San Francisco, CA, USA.

Gregory A Buck (GA)

Center for Microbiome Engineering and Data Analysis, Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA.
ORCID: 0000-0003-4621-3987

Frederic Bushman (F)

University of Pennsylvania, Philadelphia, PA, USA.

David Casero (D)

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Gerard Clarke (G)

Department of Psychiatry and Neurobehavioural Science, and APC Microbiome Ireland, University College Cork, Cork, Ireland.

Maria Carmen Collado (MC)

Institute of Agrochemistry and Food Technology-National Research Council, Valencia, Spain.

Paul D Cotter (PD)

Teagasc Food Research Centre-Moorepark, Cork, Ireland.
APC Microbiome Ireland, University College Cork, Cork, Ireland.
VistaMilk, Cork, Ireland.

John F Cryan (JF)

APC Microbiome Ireland, University College Cork, Cork, Ireland.
Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland.

Ryan T Demmer (RT)

School of Public Health, University of Minnesota, Minneapolis, MN, USA.

Suzanne Devkota (S)

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Eran Elinav (E)

Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
Microbiome and Cancer Division, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

Juan S Escobar (JS)

Vidarium-Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia.

Jennifer Fettweis (J)

Center for Microbiome Engineering and Data Analysis, Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA.

Robert D Finn (RD)

European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.

Anthony A Fodor (AA)

Department of Bioinformatics and Genomics, University of North Carolina at Charlotte, Charlotte, NC, USA.

Sofia Forslund (S)

Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité University Hospital, Berlin, Germany.

Andre Franke (A)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Cesare Furlanello (C)

HK3 Lab, Rovereto, Italy.

Jack Gilbert (J)

Department of Pediatrics and Scripps Institution of Oceanography, University of California San Diego, La Jolla, CA, USA.

Elizabeth Grice (E)

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Benjamin Haibe-Kains (B)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Scott Handley (S)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Pamela Herd (P)

McCourt School of Public Policy, Georgetown University, Washington, DC, USA.

Susan Holmes (S)

Department of Statistics, Stanford University, Stanford, CA, USA.

Jonathan P Jacobs (JP)

Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Lisa Karstens (L)

Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.

Rob Knight (R)

Center for Microbiome Innovation, University of California San Diego, La Jolla, CA, USA.

Dan Knights (D)

Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN, USA.
Biotechnology Institute, University of Minnesota, Saint Paul, MN, USA.

Omry Koren (O)

Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Douglas S Kwon (DS)

Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.

Morgan Langille (M)

Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.

Brianna Lindsay (B)

University of Maryland School of Medicine, Institute of Human Virology, Baltimore, MD, USA.

Dermot McGovern (D)

F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Alice C McHardy (AC)

Department of Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Brunswick, Germany.

Shannon McWeeney (S)

OHSU Knight Cancer Institute, Portland, OR, USA.

Noel T Mueller (NT)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Luigi Nezi (L)

Department of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Europeo di Oncologia, Milan, Italy.

Matthew Olm (M)

Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.

Noah Palm (N)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Edoardo Pasolli (E)

Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy.

Jeroen Raes (J)

Department of Microbiology and Immunology, Rega institute, KU Leuven and VIB Center for Microbiology, Leuven, Belgium.

Matthew R Redinbo (MR)

Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Malte Rühlemann (M)

Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.

R Balfour Sartor (R)

Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Patrick D Schloss (PD)

Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, USA.

Lynn Schriml (L)

University of Maryland School of Medicine, Institute for Genome Sciences, Baltimore, MD, USA.

Eran Segal (E)

Department of Computer Science, Weizmann Institute of Science, Rehovot, Israel.

Michelle Shardell (M)

University of Maryland School of Medicine, Institute for Genome Sciences, Baltimore, MD, USA.

Thomas Sharpton (T)

Department of Microbiology and Department of Statistics, Oregon State University, Corvallis, OR, USA.

Ekaterina Smirnova (E)

Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA.

Harry Sokol (H)

Gastroenterology Department, Centre de Recherche Saint-Antoine, INSERM, Assistance Publique-Hôpitaux de Paris, Saint Antoine Hospital, Sorbonne Université, Paris, France.

Justin L Sonnenburg (JL)

Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.

Sujatha Srinivasan (S)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Louise B Thingholm (LB)

Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.

Peter J Turnbaugh (PJ)

Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.

Vaibhav Upadhyay (V)

Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.

Ramona L Walls (RL)

Critical Path Institute, Tucson, AZ, USA.

Paul Wilmes (P)

Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
ORCID: 0000-0002-6478-2924

Takuji Yamada (T)

Department of Life Science and Technology, Tokyo Institute of Technology, Tokyo, Japan.
ORCID: 0000-0002-9622-1849

Georg Zeller (G)

Structural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.

Mingyu Zhang (M)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Ni Zhao (N)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Liping Zhao (L)

Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers University, New Brunswick, NJ, USA.

Wenjun Bao (W)

JMP Life Sciences, SAS Institute, Cary, NC, USA.

Aedin Culhane (A)

Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.

Viswanath Devanarayan (V)

Eisai, Woodcliff Lake, NJ, USA.

Joaquin Dopazo (J)

Clinical Bioinformatics Area, Hospital Virgen del Rocio, Sevilla, Spain.

Xiaohui Fan (X)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

Matthias Fischer (M)

Experimental Pediatric Oncology, University Children's Hospital, Cologne, Germany.
Center for Molecular Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany.

Wendell Jones (W)

Q2 Solutions-EA Genomics, Durham, NC, USA.

Rebecca Kusko (R)

Immuneering, Cambridge, MA, USA.

Christopher E Mason (CE)

Weill Cornell Medicine, New York, NY, USA.

Tim R Mercer (TR)

Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Queensland, Australia.

Susanna-Assunta Sansone (SA)

Oxford e-Research Centre, Department of Engineering Science, University of Oxford, Oxford, UK.

Andreas Scherer (A)

Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.

Leming Shi (L)

State Key Laboratory of Genetic Engineering, Human Phenome Institute, School of Life Sciences and Shanghai Cancer Center, Fudan University, Shanghai, China.

Shraddha Thakkar (S)

Office of Computational Science, Office of Translational Sciences, Center for Drug Evaluation and Research, Washington, DC, USA.

Weida Tong (W)

Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, Food & Drug Administration, Jefferson, AR, USA.

Russ Wolfinger (R)

Scientific Discovery and Genomics, SAS Institute, Cary, NC, USA.

Christopher Hunter (C)

GigaScience Database, BGI Hong Kong, Hong Kong, China.

Nicola Segata (N)

Department CIBIO, University of Trento, Trento, Italy.
Department of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico-Istituto Europeo di Oncologia, Milan, Italy.
ORCID: 0000-0002-1583-5794

Curtis Huttenhower (C)

Harvard T. H. Chan School of Public Health, Boston, MA, USA.
ORCID: 0000-0002-1110-0096

Jennifer B Dowd (JB)

Department of Sociology, Leverhulme Centre for Demographic Science, University of Oxford, Oxford, UK.

Heidi E Jones (HE)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA.
ORCID: 0000-0002-4285-3752

Levi Waldron (L)

CUNY Graduate School of Public Health and Health Policy, Institute for Implementation Science in Public Health, New York, NY, USA. levi.waldron@sph.cuny.edu.
ORCID: 0000-0003-2725-0694

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Sciences de l'information › Informatique › Biologie informatique › Reporting guidelines for human microbiome...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Dysbiose › Reporting guidelines for human microbiome...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Reporting guidelines for human microbiome...
questionsmedicales.fr › Environnement et santé publique › Environnement › Écosystème › Biodiversité › Biote › Microbiote › Reporting guidelines for human microbiome...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Études observationnelles comme sujet › Reporting guidelines for human microbiome...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Plan de recherche › Reporting guidelines for human microbiome...
questionsmedicales.fr › Disciplines des sciences naturelles › Disciplines des sciences biologiques › Science biomédicale translationnelle › Reporting guidelines for human microbiome...